[Serological response in man to an anticholera vaccine made from killed vibrios and partially purified with aluminium hydroxide].
The immunizing capability of a new anticholera vaccine (choleric anatoxin + vibrios Ogawa and Inaba) was tested on a group of 113 subjects. The vaccination was carried out with two inoculations of the vaccine, administered a month apart. Testings were taken before the vaccination, before the second inoculation and 10 to 14 days after the vaccination was completed. The determination of the vibriocide antibodies was made following the test-tube method described by Verwey and al., and the research of the antitoxic antibodies following Craig's method, using a live rabbit. Eighty two per cent of the subjects vaccinated had antitoxic antibodies with a varying strength of from 10 to greater than 320 A.U. In all those subjects treated who had previously been vaccinated at the time of the cholera epidemic with traditional vaccine, the geometric average of strength in vibriocide antibodies had increased from 2,810 to 14,700.
D000536:Aluminum Hydroxide; D000907:Antibodies, Bacterial; D000917:Antibody Formation; D002771:Cholera / Q000276:immunology; D022121:Cholera Vaccines / Q000008:administration & dosage*; D006801:Humans; D009500:Neutralization Tests; D014734:Vibrio cholerae / Q000276:immunology*
D000907:Antibodies, Bacterial; D022121:Cholera Vaccines; D000536:Aluminum Hydroxide
Risposta sierologica nell'uomo ad un vaccino anticolerico costituito da vibrioni uccisi ed anatossina parzialmente purificata con idrossido di alluminio